IE
SLS icon

Israel Englander’s SELLAS Life Sciences SLS Stock Holding History

Israel Englander’s Portfolio SLS Stock Details SLS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-159,524
Closed -$1.1M – 6359
2026
Q1 		$675K Sell
159,524
-1,228,325
-89% -$5.5M ﹤0.01% 4621
2025
Q4 		$5.23M Buy
1,387,849
+1,073,147
+341% +$2.09M ﹤0.01% 2953
2025
Q3 		$507K Sell
314,702
-812,523
-72% -$1.45M ﹤0.01% 5063
2025
Q2 		$2.47M Buy
+1,127,225
New +$1.73M ﹤0.01% 3692
2024
Q4 		– Sell
-46,335
Closed -$57.9K – 6424
2024
Q3 		$57.9K Sell
46,335
-104,113
-69% -$127K ﹤0.01% 5669
2024
Q2 		$179K Buy
+150,448
New +$205K ﹤0.01% 5181
2024
Q1 		– Sell
-11,239
Closed -$11.9K – 6611
2023
Q4 		$11.9K Buy
+11,239
New +$12.2K ﹤0.01% 5715
2023
Q1 		– Sell
-61,179
Closed -$144K – 6820
2022
Q4 		$144K Buy
61,179
+36,396
+147% +$102K ﹤0.01% 5457
2022
Q3 		$50K Buy
+24,783
New +$68.4K ﹤0.01% 6186
2021
Q4 		– Sell
-12,161
Closed -$111K – 7334
2021
Q3 		$111K Buy
+12,161
New +$113K ﹤0.01% 6391
2019
Q3 		– Sell
-423
Closed -$2K – 4516
2019
Q2 		$2K Buy
+423
New +$15K ﹤0.01% 3989
2017
Q4 		– Sell
-45
Closed -$24K – 4051
2017
Q3 		$24K Sell
45
-30
-40% -$19.8K ﹤0.01% 3441
2017
Q2 		$65K Sell
75
-131
-64% -$114K ﹤0.01% 3344
2017
Q1 		$188K Sell
206
-6
-3% -$9.94K ﹤0.01% 3224
2016
Q4 		$618K Buy
+212
New +$1.23M ﹤0.01% 2557

Other funds holding SLS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
AFM
Anson Funds Management Dallas, Texas $1.68B AUM 374.31% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
Jones Financial Companies
Jones Financial Companies Des Peres, Missouri $250B AUM 21.32% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

Israel Englander's SLS Position: Q2 2026 in Review

Israel Englander sold out of SELLAS Life Sciences (SLS) in Q2 2026, closing a stake of 159,524 shares — an estimated $1.1M sold.

Israel Englander first reported a position in SLS in Q4 2016 and held it in 15 quarters. The position peaked at $5.23M in Q4 2025. 190 funds tracked by Wall St. Rank hold SLS as of Q2 2026.

  • Israel Englander reported no remaining SELLAS Life Sciences position as of Q2 2026 after selling out during the quarter.
  • Israel Englander sold 159,524 SELLAS Life Sciences shares in Q2 2026, an estimated $1.1M.
  • Israel Englander first reported a position in SELLAS Life Sciences in Q4 2016 and held it in 15 quarters.
  • Israel Englander's SELLAS Life Sciences position peaked at $5.23M in Q4 2025.
  • 190 funds tracked by Wall St. Rank held SELLAS Life Sciences as of Q2 2026.

Based on Millennium Management's 13F filing for Q2 2026, filed 14 Aug 2026.